πŸ‡ΊπŸ‡Έ FDA
Patent

US 10449203

Tianeptine oxalate salts and polymorphs

granted A61KA61K31/554A61P

Quick answer

US patent 10449203 (Tianeptine oxalate salts and polymorphs) held by TONIX PHARMA LIMITED expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TONIX PHARMA LIMITED
Grant date
Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/554, A61P, A61P11/00, A61P11/06